Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Next Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS You Might Also Like RRP Patient Meeting 2023: NIH RUNX1 Clinical Study Update - Dr. David Young RUNX1 Attenuates Toll-Like Receptor and Type I Interferon Signaling in Neutrophils RRP Patient Meeting 2023: Scientific Conference Outcomes and Updates RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Next Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS You Might Also Like RRP Patient Meeting 2023: NIH RUNX1 Clinical Study Update - Dr. David Young RUNX1 Attenuates Toll-Like Receptor and Type I Interferon Signaling in Neutrophils RRP Patient Meeting 2023: Scientific Conference Outcomes and Updates RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
